UMich Publishes Clinical Cancer Sequencing Protocol; Will Scale up to 100 Patients Next Year | GenomeWeb

By Monica Heger

This article was originally published Dec. 2.


The University of Michigan
's Center for Translational Pathology has completed a pilot study demonstrating how it plans to use next-generation sequencing of its cancer patients to guide the next course of treatment, including matching patients to available clinical trials.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.